Response to: 'Some concerns from Turkey' by Bilgin et al

Affiliations

¹ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
² Division of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
³ Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.
⁴ Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
⁵ Department of Rheumatology and Clinical Immunology, Kyoto University, Kyoto, Japan.
⁶ Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
⁷ The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
⁸ Department of Preventive Medicine and Public Health, Biostatistics at Clinical and Translational Research Center, Keio University School of Medicine, Tokyo, Japan.
⁹ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan tsutake@z5.keio.jp.

Comment

Yuko Kaneko et al. Ann Rheum Dis. 2020 Feb.

. 2020 Feb;79(2):e16.

doi: 10.1136/annrheumdis-2018-214776. Epub 2018 Dec 8.

¹ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
² Division of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
³ Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.
⁴ Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
⁵ Department of Rheumatology and Clinical Immunology, Kyoto University, Kyoto, Japan.
⁶ Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
⁷ The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
⁸ Department of Preventive Medicine and Public Health, Biostatistics at Clinical and Translational Research Center, Keio University School of Medicine, Tokyo, Japan.
⁹ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan tsutake@z5.keio.jp.

No abstract available

Keywords: NSAIDs; disease activity; treatment.

Conflict of interest statement

Competing interests: None declared.

Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.
Kaneko Y, Kameda H, Ikeda K, Ishii T, Murakami K, Takamatsu H, Tanaka Y, Abe T, Takeuchi T. Kaneko Y, et al. Ann Rheum Dis. 2018 Dec;77(12):1720-1729. doi: 10.1136/annrheumdis-2018-213920. Epub 2018 Oct 2. Ann Rheum Dis. 2018. PMID: 30279267 Clinical Trial.
Some concerns from Turkey.
Bilgin E, Ozarli İ, Kılıç L, Bölek EÇ, Yardımcı GK, Karadağ Ö. Bilgin E, et al. Ann Rheum Dis. 2020 Feb;79(2):e15. doi: 10.1136/annrheumdis-2018-214739. Epub 2018 Nov 24. Ann Rheum Dis. 2020. PMID: 30472654 No abstract available.